Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and in the USA for the treatment for HIV/AIDS, where resistance, toxicity, adherence and cost limit the use of drugs. The Company’s vaccine composition mimics the successful induction of antiviral immune responses via plasmid DNA expressing dendritic cells and the non-viral vaccine delivery enhances the activation of therapeutic T cell responses. The vaccine applied topically using an experimental medical device that targets the vaccine to epidermal Langerhans cells. The Company’s proprietary technology provides a versatile chance for an exceptional growth in the infectious disease and cancer market that is characterized with rising unmet medical need worldwide

Contact Details: 2233 Wisconsin Avenue, NWSuite 503 Washington District of Columbia 20007 United States of America Tel: 1 202 345 0011 Fax: Email: dermavir@geneticimmunity.com WWW: www.geneticimmunity.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 298 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: genetic immunity llc | genetic immunity definition | genetic immunity | GENETIC IMMUNITY IS KNOWN BY WHAT TERM | genetic immunity llc | t | genetic immunity | Genetic Immunity | genetic immunity | Genetic Immunity | .

Search for more companies in Washington

Search for more companies in District of Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genetic Immunity, LLC